Managing cancer pain: Frequently asked questions

Cleveland Clinic Journal of Medicine

Volumn 78, Issue 7, 2011, Pages 449-464

  Induru, Raghava R ^a   Lagman, Ruth L ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ALTERNATIVE MEDICINE; ARTICLE; DRUG COMBINATION; HUMAN; NEOPLASM; PAIN; PAIN ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY;

ANALGESICS; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMPLEMENTARY THERAPIES; DRUG THERAPY, COMBINATION; HUMANS; NEOPLASMS; PAIN; PAIN MEASUREMENT;

EID: 79960145612     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.78a.10054     Document Type: Article

References (63)

1. Laird B, Colvin L, Fallon M. Management of cancer pain: basic principles and neuropathic cancer pain. Eur J Cancer 2008; 44:1078-1082.
2. Chang HM. Cancer pain management. Med Clin North Am 1999; 83:711-736
3. Stannard C, Johnson M. Chronic pain management-can we do better? An interview-based survey in primary care. Curr Med Res Opin 2003; 19:703-706.
4. Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999; 353:1695-1700.
5. Walsh D, Rivera NI, Davis MP, Lagman R, Legrand SB. Strategies for pain management: Cleveland Clinic Foundation guidelines for opioid dosing for cancer pain. Support Cancer Ther 2004; 1:157-164.
6. F oley KM. Acute and chronic pain syndromes. In: Doyle D, Hanks G, Cherny N, Calman K, editors. Oxford Textbook of Palliative Medicine. 3rd ed. Oxford, UK: Oxford University Press; 2005:298-316.
7. Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain 2003; 4:2-21.
8. Jensen MP, Turner JA, Romano JM. What is the maximum number of levels needed in pain intensity measurement? Pain 1994; 58:387-392.
9. Preston CC, Colman AM. Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences. Acta Psychol (Amst) 2000; 104:1-15.
10. Peretti-Watel P, Bendiane MK, Obadia Y, Favre R, Lapiana JM, Moatti JP; South-Eastern France Palliative Care Group. The prescription of opioid analgesics to terminal cancer patients: impact of physicians' general attitudes and contextual factors. Palliat Support Care 2003; 1:345-352.
11. Jacobsen R, Liubarskiene Z, Møldrup C, Christrup L, Sjøgren P, Samsanaviciene J. Barriers to cancer pain management: a review of empirical research. Medicina (Kaunas) 2009; 45:427-433.
12. Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med 2007; 8:573-584.
13. R ome HP Jr, Rome JD. Limbically augmented pain syndrome (LAPS): kindling, corticolimbic sensitization, and the convergence of affective and sensory symptoms in chronic pain disorders. Pain Med 2000; 1:7-23.
14. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain 1992; 8:77-85.
15. Murányi M, Radák Z. Pain and opioids. Orv Hetil 2008; 149:2363-2370.
16. Vadalouca A, Moka E, Argyra E, Sikioti P, Siafaka I. Opioid rotation in patients with cancer: a review of the current literature. J Opioid Manag 2008; 4:213-250.
17. Galvagno SM, Correll DJ, Narang S. Safe oral equianalgesic opioid dosing for patients with moderate-to-severe pain. www.hcplive.com/publications/Resident-and-Staff/2007/2007-04/2007-04_06. Accessed May 25, 2011.
18. Walsh D. Pharmacological management of cancer pain. Semin Oncol 2000; 27:45-63.
19. Shaheen PE, Walsh D, Lasheen W, Davis MP, Lagman RL. Opioid equianalgesic tables: are they all equally dangerous? J Pain Symptom Manage 2009; 38:409-417.
20. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage 2001; 22:672-687.
21. Harris JD. Management of expected and unexpected opioid-related side effects. Clin J Pain 2008; 24(suppl 10):S8-S13.
22. Cherny N, Ripamonti C, Pereira J; Expert Working Group of the European Association of Palliative Care Network. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001; 19:2542-2554.
23. Harris JD, Kotob F. Management of opioid-related side effects. In: de Leon-Casasola OA, ed. Cancer Pain: Pharmacological, Interventional and Palliative Care. Philadelphia: Elsevier Inc; 2006:207-230.
24. Mercadante S. Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 1999; 86:1856-1866.
25. Cheema B, Lagman RL, Walsh D, et al. A prospective study of opioid rotation in pain due to advanced cancer. J Cancer Pain & Symp Palliat 2006; 2:39-46.
26. Schug SA, Zech D, Grond S, Jung H, Meuser T, Stobbe B. A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage 1992; 7:259-266.
27. Clarke SF, Dargan PI, Jones AL. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J 2005; 22:612-616.
28. Knotkova H, Pappagallo M. Adjuvant analgesics. Med Clin North Am 2007; 91:113-124.
29. Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in cancer pain management. Oncologist 2004; 9:571-591.
30. Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancerrelated pain. J Pain Symptom Manage 2010; 39:167-179.
31. Mercadante S. The use of anti-inflammatory drugs in cancer pain. Cancer Treat Rev 2001; 27:51-61.
32. Davis MP, Walsh D, Lagman R, LeGrand SB. Controversies in pharmacotherapy of pain management. Lancet Oncol 2005; 6:696-704.
33. Klotz U. Tramadol-the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain. Arzneimittelforschung 2003; 53:681-687.
34. Davis MP, Lasheen W, Gamier P. Practical guide to opioids and their complications in managing cancer pain. What oncologists need to know. Oncology (Williston Park) 2007; 21:1229-1238.
35. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 2004; 28:497-504.
36. Davis MP. Buprenorphine in cancer pain. Support Care Cancer 2005; 13:878-887.
37. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 1996; 11:203-217.
38. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 2008; 24:497-508.
39. Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003; 97:1097-1102
40. Passik SD, Kirsh KL. Managing pain in patients with aberrant drugtaking behaviors. J Support Oncol 2005; 3:83-86.
41. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998; 83:777-782.
42. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280:1569-1575.
43. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 18:2505-2514.
44. Adler SR, Fosket JR. Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract 1999; 48:453-458.
45. Newell S, Sanson-Fisher RW. Australian oncologists' self-reported knowledge and attitudes about non-traditional therapies used by cancer patients. Med J Aust 2000; 172:110-113.
46. Berman BM, Singh BK, Lao L, Singh BB, Ferentz KS, Hartnoll SM. Physicians' attitudes toward complementary or alternative medicine: a regional survey. J Am Board Fam Pract 1995; 8:361-366.
47. Verhoef MJ, Sutherland LR. General practitioners' assessment of and interest in alternative medicine in Canada. Soc Sci Med 1995; 41:511-515.
48. American Cancer Society: Treatment guidelines for patients. Version http://www.cancer.org/downloads/CRI/NCCN_pain.pdf.
49. Benedetti C, Brock C, Cleeland C, et al; National Comprehensive Cancer Network. NCCN Practice Guidelines for Cancer Pain. Oncology (Williston Park) 2000; 14:135-150.
50. Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ. Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol 2006; 24:5457-5464.
51. Lee H, Schmidt K, Ernst E. Acupuncture for the relief of cancerrelated pain-a systematic review. Eur J Pain 2005; 9:437-444.
52. Alimi D, Rubino C, Pichard-Léandri E, Fermand-Brulé S, Dubreuil-Lemaire ML, Hill C. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol 2003; 21:4120-4126.
53. Spiegel D, Bloom JR. Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 1983; 45:333-339.
54. G oodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001; 345:1719-1726.
55. Syrjala KL, Donaldson GW, Davis MW, Kippes ME, Carr JE. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain 1995; 63:189-198.
56. Sloman R, Brown P, Aldana E, Chee E. The use of relaxation for the promotion of comfort and pain relief in persons with advanced cancer. Contemp Nurse 1994; 3:6-12.
57. Weinrich SP, Weinrich MC. The effect of massage on pain in cancer patients. Appl Nurs Res 1990; 3:140-145.
58. Wilkie DJ, Kampbell J, Cutshall S, et al. Effects of massage on pain intensity, analgesics and quality of life in patients with cancer pain: a pilot study of a randomized clinical trial conducted within hospice care delivery. Hosp J 2000; 15:31-53.
59. Soden K, Vincent K, Craske S, Lucas C, Ashley S. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med 2004; 18:87-92.
60. Post-White J, Kinney ME, Savik K, Gau JB, Wilcox C, Lerner I. Therapeutic massage and healing touch improve symptoms in cancer. Integr Cancer Ther 2003; 2:332-344.
61. Olson K, Hanson J, Michaud M. A phase II trial of Reiki for the management of pain in advanced cancer patients. J Pain Symptom Manage 2003; 26:990-997.
62. G allagher LM, Lagman R, Walsh D, Davis MP, Legrand SB. The clinical effects of music therapy in palliative medicine. Support Care Cancer 2006; 14:859-866.
63. Olaku O, White JD. Herbal therapy use by cancer patients: a literature review on case reports. Eur J Cancer 2011; 47:508-514.